The Contradiction Conundrum: New digital pharma report
April 27, 2022 | Digital Product Design, Mindset and Culture, User Research, digital strategy
New research, based on the views of 450 pharma professionals, reveals contradictions in how pharma organisations are approaching their digital products and strategies.
This week, we’re excited to be releasing our new report, The Contradiction Conundrum.
The research, conducted in partnership with Reuters Events, explores how pharma organisations are currently approaching their digital products, services and strategies.
The rapid digital transformation in pharma in recent years has been nothing short of remarkable. Decades worth of digital progress and innovation have been accomplished in just a few years, with organisations responding to changing customer demands and introducing new ways of working. Health and pharma industries are booming, and on the precipice of huge disruption.
Contradictions in digital approaches
Our research reveals a sector that is excited about the opportunities presented through digital product design. But, despite this optimism regarding the possibilities, confidence in the ability to execute is mixed. This is highlighted through a number of key contradictions facing the pharma sector.
For example, despite widespread understanding of the value of digital in pharma and the need to make it a future priority, only 4% of digital product launches are regularly succeeding.
Themes covered in The Contradiction Conundrum include digital best practice and execution, the fundamentals of a successful digital strategy, sources of insight for key decision-making, organisational and individual mindsets, and the role of user research within digital.
Based on the views of 450 pharma professionals, the report features original data, expert perspectives, and practical advice.
In it, we explore how, through deepening audience understanding and building the right internal processes, you can overcome any contradiction.
View and download the report here.
By elevating their digital products and services, pharma teams have a unique chance to differentiate themselves, improve engagement and add value to their customer relationships.
We hope that you find it an interesting and thought-provoking read, and we encourage you to ask yourself — are you doing enough to ensure your digital product launches deliver?
New to Graphite?
We’re a digital customer experience agency that collaborates with healthcare and pharmaceutical organisations to deepen audience connection through meaningful digital experiences. We help clients create effective digital products using strategy, user research, and UX and UI design.
This content was provided by Graphite Digital
Company Details
Latest Content from Graphite Digital
First impressions matter: Why getting your onboarding right is key for digital engagement
As pharma organisations invest extensively in creating engaging content, the onboarding process must not be overlooked. Seamless onboarding is the key to ensuring that HCPs not only meet regulatory standards,...
Pharma’s digital dilemma: Finding the balance between speed, scale, and experience
What’s holding pharma back from true digital transformation? At NEXT Pharma 2025, Our CEO Rob Verheul and Roeland van der Heiden (AstraZeneca) argued it starts with design systems. This quick...
Redefining digital ROI: Engagement, experience, and the new metrics of success
Clicks and engagement only tell part of the story. In this webinar, pharma leaders discuss how to move beyond traditional KPIs to measure real impact and ROI from digital and...
5 key digital CX challenges in pharma, and how to start solving them
Creating great digital experiences in pharma isn’t easy, but progress doesn’t always need to come from big projects or budgets. Here are 5 common challenges that leading digital teams are...
Driving behaviour change for positive patient outcomes in pharma
Discover how pharma can help to achieve better patient health outcomes by informing patient behaviour through insights, strategy and collaboration.
How Design Systems enable streamlined regulatory approval in digital pharma
The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...
Disconnected pharma: Navigating digital challenges and priorities in 2024
We are delighted to present Graphite’s research whitepaper for 2024 — and this year we are able to share the challenges and priorities that digital leaders are finding, in this...
How to successfully manage change and enable digital transformation within pharma
Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation...
How Design Systems enable streamlined regulatory approval in digital pharma
The strict compliance guidelines that exist within pharma can mean that digital content and platforms can take a long time to be approved and involve lots of back and forth...
Ensuring a seamless transition from design to development: Strategies for successful collaboration
When designing digital products and services, the process of transitioning from design to development plays a critical role in bringing concepts to life. Our Design Lead, Edward Hart, explains why...
- 1
- 2